GABAergic Neurons in Neurodegeneration

GABAergic Neurons in Neurodegeneration

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABAergic Neurons in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4300028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4300028)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">PV basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">CCK basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">Axo-axonic cells</td>
<td>Axon initial segment</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">SST interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">VIP interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">Neurogliaform cells</td>
<td>Distal dendrites</td>
</tr>
<tr>
<td class="label">S

GABAergic Neurons in Neurodegeneration

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABAergic Neurons in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4300028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4300028)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">PV basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">CCK basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">Axo-axonic cells</td>
<td>Axon initial segment</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">SST interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">VIP interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">Neurogliaform cells</td>
<td>Distal dendrites</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Location</td>
</tr>
<tr>
<td class="label">α1</td>
<td>Widely distributed</td>
</tr>
<tr>
<td class="label">α2</td>
<td>Anxiety, motor</td>
</tr>
<tr>
<td class="label">α3</td>
<td>Sparse</td>
</tr>
<tr>
<td class="label">α5</td>
<td>Hippocampus</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">GABA-A modulators</td>
<td>Cl- channel</td>
</tr>
<tr>
<td class="label">GABA-B agonists</td>
<td>GPCR</td>
</tr>
<tr>
<td class="label">Neurosteroids</td>
<td>Allosteric sites</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>Diazepam</td>
</tr>
<tr>
<td class="label">Barbiturates</td>
<td>Phenobarbital</td>
</tr>
<tr>
<td class="label">Neurosteroids</td>
<td>Allopregnanolone</td>
</tr>
<tr>
<td class="label">Oscillation Type</td>
<td>Frequency</td>
</tr>
<tr>
<td class="label">Gamma</td>
<td>30-100 Hz</td>
</tr>
<tr>
<td class="label">Beta</td>
<td>13-30 Hz</td>
</tr>
<tr>
<td class="label">Theta</td>
<td>4-8 Hz</td>
</tr>
<tr>
<td class="label">Ripple</td>
<td>150-200 Hz</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Change</td>
</tr>
<tr>
<td class="label">GABA-A α1</td>
<td>Downregulated</td>
</tr>
<tr>
<td class="label">GABA-A α5</td>
<td>Altered</td>
</tr>
<tr>
<td class="label">GABA-B</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">KCC2</td>
<td>Downregulated</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">GABA-A α1</td>
<td>Positive allosteric modulators</td>
</tr>
<tr>
<td class="label">GABA-A α5</td>
<td>Selective modulators</td>
</tr>
<tr>
<td class="label">GABA-B</td>
<td>Baclofen derivatives</td>
</tr>
<tr>
<td class="label">KCC2</td>
<td>Enhancers</td>
</tr>
</table>

Gabaergic Neurons In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: GABAergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
• [OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
• [OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Introduction

GABAergic neurons are inhibitory neurons that utilize gamma-aminobutyric acid (GABA) as their primary neurotransmitter. They play crucial roles in maintaining neural circuit balance, preventing hyperexcitability, and coordinating information processing throughout the brain. Dysfunction of GABAergic neurons contributes significantly to hyperexcitability, seizures, and network dysfunction observed in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis[@palop2010].

Classification of GABAergic Neurons

Cortical and Hippocampal Interneurons

GABAergic interneurons in the cortex and hippocampus are remarkably diverse[@freund2007]:

Perisomatic Inhibitors

Dendritic Inhibitors

Other Interneurons

• CCK-expressing interneurons: Diverse functions
• Ivy cells: NPY co-expression
• Mystery cells: Emerging populations

Subcortical GABAergic Populations

Basal Ganglia

• Striatal medium spiny neurons (MSNs): Primary output neurons
• Fast-spiking interneurons: Local inhibition
• Globus pallidus neurons: Inhibitory output
• Substantia nigra pars reticulata: Motor inhibition

Thalamus

• Thalamic reticular nucleus (TRN): Gating and attention
• Thalamic interneurons: Local processing

Other Regions

• Cerebellar interneurons: Purkinje cell modulation
• Brainstem nuclei: Autonomic control
• Hypothalamic populations: Homeostatic regulation

Molecular Mechanisms

GABA Synthesis and Release

GABAergic neurotransmission depends on specific machinery[@benarroch2007]:

• GAD67 (GAD1): Primary synthesizing enzyme
• GAD65 (GAD2): Synaptic vesicle localization
• VGAT (VIAAT): Vesicular transporter
• GABA transporters (GATs): Reuptake

Receptor Subtypes

GABA-A Receptors

Ligand-gated chloride channels with multiple subunits:

GABA-B Receptors

Metabotropic receptors:

• G-protein coupled (Gi/o)
• Pre-synaptic: Ca2+ inhibition
• Post-synaptic: K+ channel activation

Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

GABAergic dysfunction in AD is extensive[@zhou2022]:

Changes Observed

• PV neuron loss: Specific vulnerability in hippocampus
• SST neuron alterations: Early changes
• Network hyperexcitability: Seizure susceptibility
• GABA levels: Often reduced in CSF

Mechanisms

• Direct toxicity to interneurons
• Receptor dysfunction
• Synaptic impairment

• Neuronal loss
• Circuit disconnection

• Oscillation disruption
• Memory circuit impairment
• Hyperexcitability

Therapeutic Implications

Parkinson's Disease

GABAergic changes in PD are central to motor dysfunction[@albin2002]:

Basal Ganglia Alterations

• Striatal MSNs: Firing rate changes
• GPe hyperactivity: Increased inhibition
• GPi/SNr output: Excessive inhibition
• STN activity: Disrupted

Motor Symptoms

• Bradykinesia
• Rigidity
• Tremor (less prominent)

Treatment Effects

• L-DOPA: Modifies GABAergic activity
• DBS: Normalizes pathological patterns
• Dyskinesias: GABAergic involvement

Huntington's Disease

GABAergic loss is early and progressive[@albin2020]:

Striatal Vulnerability

• MSNs early loss: Most vulnerable
• Interneuron preservation: Relative
• Indirect pathway: Particularly affected

Pathophysiology

• Loss of inhibition
• Hyperexcitability
• Network breakdown
• Hyperkinetic movements

Amyotrophic Lateral Sclerosis

Cortical hyperexcitability features prominently[@turner2018]:

• Cortical GABAergic dysfunction: Early
• Inhibitory neuron loss: Variable
• Receptor changes: Altered subunit composition
• Excitability: Increased

Therapeutic Approaches

Pharmacological Modulation

GABA-A Targeting Drugs

GABA-B Targeting

• Baclofen: Spasticity, being explored for ALS
• CGP-55845: Research tool
• Arbaclofen: Clinical trials

Novel Approaches

• GABA-A α5-selective modulators: Cognitive effects
• Targeted delivery: Region-specific
• Gene therapy: GAD delivery

Emerging Strategies

Cell-Based Therapy

• GABAergic progenitor transplantation: Preclinical
• iPSC-derived neurons: Patient-specific
• Direct conversion: Glia to neurons

Gene Therapy

• GAD1/GAD2 delivery: Increase GABA synthesis
• Receptor modification: Enhance sensitivity
• Channel engineering: Circuit-specific

Biomarkers

• CSF GABA: Biomarker potential
• MRS imaging: Cortical GABA levels
• PET ligands: Receptor imaging

Circuit Dysfunction in Neurodegeneration

Network Hyperexcitability Mechanisms

The loss of GABAergic inhibition leads to network hyperexcitability through several interconnected mechanisms[@palop2010][@li2021]:

Oscillation Disruption

GABAergic interneurons are critical for generating brain oscillations:

The disruption of these oscillations contributes to cognitive decline in neurodegenerative diseases[@klausberger2003][@hu2014].

Specific Vulnerabilities

Parvalbumin (PV) Neurons

PV-expressing interneurons are particularly vulnerable in several conditions[@kelley2018][@murray2018]:

Somatostatin (SST) Neurons

SST neurons show early dysfunction in AD:

• Target dendritic shafts of pyramidal neurons
• Regulate input integration
• Vulnerable to amyloid toxicity
• Changes precede PV neuron loss

Molecular Mechanisms of Vulnerability

Intrinsic Mechanisms

GABAergic neurons exhibit specific vulnerabilities[@marin2012][@gondora2019]:

Synaptic Mechanisms

Receptor Alterations

Specific receptor changes in GABAergic neurons[@whitt2018][@devore2020]:

Basal Ganglia Dysfunction in Movement Disorders

Parkinson's Disease

GABAergic changes in PD are central to motor dysfunction[@pal2019][@espay2014]:

Treatment Implications:

• L-DOPA modifies GABAergic activity but causes dyskinesias
• Deep brain stimulation (DBS) normalizes pathological patterns
• GABAergic drugs may help manage motor symptoms

Huntington's Disease

GABAergic loss is early and progressive[@burkhardt2008][@gruber2019]:

Therapeutic Targeting

Amyotrophic Lateral Sclerosis

Cortical Hyperexcitability

ALS features prominent cortical hyperexcitability[@turner2018][@fischer2020]:

Therapeutic Strategies[@menichetti2019]

• GABA-A modulators: Restore inhibition
• GABA-B agonists: Enhance presynaptic inhibition
• Cell therapy: GABAergic progenitor transplantation
• Gene therapy: GAD delivery to increase GABA synthesis

Biomarkers and Diagnostics

Current Approaches

• CSF GABA: Marker of GABAergic function
• MRS Imaging: Non-invasive cortical GABA measurement
• PET Ligands: GABA receptor imaging
• EEG: Network dysfunction quantification

Emerging Biomarkers

• Interneuron-specific protein markers
• Gene expression signatures
• Single-cell electrophysiology patterns

Research Directions

Unresolved Questions

Future Directions

• Single-cell transcriptomics to identify novel targets
• Optogenetic approaches for cell-type specific manipulation
• Translational studies in patient-derived models
• Biomarker development for early detection

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [GABA Receptors](/proteins/gaba-receptors)
• [Parvalbumin Interneurons](/cell-types/parvalbumin-neurons)
• [Basal Ganglia](/brain-regions/basal-ganglia)
• [Network Hyperexcitability](/mechanisms/network-hyperexcitability)

External Links

• [GABA and Inhibitory Neurons - Allen Brain Atlas](https://mouse.brain-map.org/)
• [GABA Receptor Structure - PDB](https://www.rcsb.org/)
• [Neurodegeneration Research - NIH](https://www.ninds.nih.gov/)
• [Interneuron Diversity - Neuron](https://www.sciencedirect.com/journal/neuron)

Pathway Diagram

The following diagram shows the key molecular relationships involving GABAergic Neurons in Neurodegeneration discovered through SciDEX knowledge graph analysis: